Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company headquartered in Dublin, Ireland, is attracting significant attention from investors due to its robust late-stage clinical pipeline and potential for substantial upside...
Emergent BioSolutions Inc. (NYSE: EBS) presents an intriguing opportunity for investors, particularly those focused on the healthcare sector. Specializing in preparedness and response solutions for various public health threats, Emergent..
AngioDynamics, Inc. (NASDAQ: ANGO), a leading player in the healthcare sector specializing in medical instruments and supplies, offers a tantalizing opportunity for investors with a potential upside of 77.86%. With..
Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company with a market capitalization of $33.83 million, is capturing investor attention with a staggering potential upside of 962.50%. Operating in the healthcare..
Fortrea Holdings Inc. (FTRE), a promising player in the biotechnology industry, presents a compelling opportunity for investors searching for growth in the healthcare sector. With its headquarters in Durham, North..
Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing the attention of investors with a remarkable potential upside of 72.76%. Positioned in the dynamic biotechnology industry within the healthcare sector, this Boston-based..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has emerged as a captivating story in the biotechnology sector, offering investors a promising opportunity with a potential upside of 53.29%. This clinical-stage biopharmaceutical company,..
Treace Medical Concepts, Inc. (NASDAQ: TMCI), a promising player in the healthcare sector specializing in medical devices, has recently captured investor attention due to its substantial potential upside. With a..
In the rapidly evolving field of biotechnology focused on mental health, COMPASS Pathways Plc (NASDAQ: CMPS) stands out with a remarkable potential upside of 223.49%. This company, headquartered in London,..
